Indalo Therapeutics
Dedicated to developing novel treatments for fibrotic diseases.
Dedicated to developing novel treatments for fibrotic diseases.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
St. Louis, MOInitial Investment
2017Indalo Therapeutics, a preclinical biotechnology company dedicated to developing therapies for fibrosis, is formed with an experienced team, strong IP, and robust portfolio of drug candidates.